Bio-Gene Advances Flavocide Safety Studies as Qcide Deal Targets Japan’s $1bn Pest Market

FierceBiotechLilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’

Endpoints NewsBiopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more

Clinical OMICsLong-Read DNA Test Could Replace 15 Existing Tests for Rare Diseases

Clinical OMICsMaternal Blood Test Allows Comprehensive Genetic Fetal Screening

Endpoints NewsMerck brings Welireg-Keytruda combo to treat kidney cancer

FDA News ReleasesFDA Clears First Over-the-Counter Continuous Glucose Monitor for Children

Clinical OMICsFrom Multi-Omics to Digital Twins: A Data-Driven Future for Precision Medicine

Clinical OMICsAge-Related Mutations in Brain Immune Cells Linked to Alzheimer’s Inflammation

Clinical OMICsPaper Mills and the Fight Against Scientific Fraud

Clinical OMICsNanowire Device Captures EVs for Targeted Cancer Liquid Biopsies

CellComplete biosynthesis of the anticancer cephalotaxinone and homoerythratine

Endpoints NewsAmgen and the FDA want two different outcomes for Tavneos. What will patients do?